Zobrazeno 1 - 10
of 68
pro vyhledávání: ''
Autor:
El-Sayed M. El-Sayed, Gouda K. Helal, Khalid S. Hassanien, Zakarya M. Zakarya, Raed S. Ismail
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:942-949
WHAT IS KNOWN AND OBJECTIVE Sofosbuvir has been approved as the first nonstructural protein 5B polymerase inhibitor with pan-genotypic activity against the hepatitis C (HCV) virus. Daclatasvir is a first-in-class hepatitis C virus nonstructural prote
Publikováno v:
Mediators of Inflammation, Vol 2020 (2020)
Mediators of Inflammation
Mediators of Inflammation
Background. Renal anemia is a common complication of hemodialysis patients. Erythropoietin (EPO) hyporesponsiveness has been recognized as an important factor to poor efficacy of recombinant human erythropoietin in the treatment of renal anemia. More
Autor:
Hamidreza Poorhosseini, Seyed Khalil Forouzannia, Seyed Hossein Ahmadi Tafti, Masoumeh Lotfi-Tokaldany, Negar Omidi, Shahrzad Salehbeigi
Publikováno v:
Journal of Cardiac Surgery
Background The disturbance in the international normalized ratio (INR) in patients receiving warfarin therapy is of concern. We aimed to evaluate coagulation features in hospitalized patients under warfarin treatment for prosthetic heart valves durin
Autor:
Takayuki Baba, Hirotaka Yokouchi, Mariko Kubota-Taniai, Masayasu Kitahashi, Shuichi Yamamoto, Takehito Iwase
Publikováno v:
BioMed Research International, Vol 2020 (2020)
BioMed Research International
BioMed Research International
The purpose of this study was to evaluate the long-term effects of half-time photodynamic therapy (PDT) on the retinal sensitivity in eyes with chronic central serous chorioretinopathy (CSC). Twenty-two eyes of 22 patients with chronic CSC were studi
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 45:1390-1397
WHAT IS KNOWN AND OBJECTIVE Cystatin C (Cys-C) is a useful diagnostic marker for early renal dysfunction, but has the disadvantage of giving false-positive results when corticosteroids are administered. In this study, we aimed to evaluate the dose-de
Autor:
Gudrun von Scheven, Yves Artur, Claudia Borsa, Maria Moreno-Villanueva, Philippe Faure, Daniela Gradinaru, Lucie Oziol, Cristina Ionescu, Anca Ungurianu, Alexander Bürkle, Denisa Margina
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Hindawi, 2020, 2020, pp.3580934. ⟨10.1155/2020/3580934⟩
Oxidative Medicine and Cellular Longevity, Vol 2020 (2020)
Oxidative Medicine and Cellular Longevity, Hindawi, 2020, 2020, pp.3580934. ⟨10.1155/2020/3580934⟩
Oxidative Medicine and Cellular Longevity, Vol 2020 (2020)
International audience; Ionizing radiation induces genomic instability in living organisms, and several studies reported an ageing-dependent radiosensitivity. Chemical compounds, such as scavengers, radioprotectors, and modifiers, contribute to reduc
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 45:191-198
What is known and objective As terlipressin becomes more widely used in clinical practice, more papers had reported the correlation between hyponatremia and terlipressin treatment. This study was performed to evaluate the clinical characteristics and
Autor:
Renwang Chen, Qiu-Shuang Wang, Fei Sun, Yi-Fan Zhang, Shengli Yang, Jian-Li Hu, Liang-Liang Shi
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
Objective. Accumulating evidence suggests that pseudogenes play potential roles in the regulation of their cognate wild-type genes, oncogenes, and tumor suppressor genes. ANXA2P2 (annexin A2 pseudogene 2) is one of three pseudogenes of annexin A2 tha
Autor:
Mahmoud El-Meteini, Manal El-Hamamsy, Azza El‐Sayed Mansy, Iman F. Montasser, Dina Ezzeldin Nabet
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 44:447-453
What is known and objective The influence of immunosuppression on the response to antiviral therapy (AVT) for recurrent hepatitis C virus (HCV) infection in liver transplant (LT) recipients remains controversial, especially for the rarely investigate
Publikováno v:
BioMed Research International, Vol 2018 (2018)
BioMed Research International
BioMed Research International
Background. Refractory and relapsed multiple myeloma (RRMM) remains a clinical challenge. We compared the progression-free survival (PFS) of RRMM patients treated with lenalidomide and low dose dexamethasone plus elotuzumab or carfilzomib (ELD vs. CL